BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges. Cell Mol Life Sci 2022;79:219. [PMID: 35366105 DOI: 10.1007/s00018-022-04225-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hanaford A, Johnson SC. The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet J Rare Dis 2022;17:335. [PMID: 36056365 DOI: 10.1186/s13023-022-02495-3] [Reference Citation Analysis]
2 Lim KY, Kim SI, Kim H, Kang J, Park JW, Won JK, Shin DY, Park SH. Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate. BMC Neurol 2022;22:288. [PMID: 35922754 DOI: 10.1186/s12883-022-02818-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Masdeu JC, Pascual B, Fujita M. Imaging Neuroinflammation in Neurodegenerative Disorders. J Nucl Med 2022;63:45S-52S. [PMID: 35649654 DOI: 10.2967/jnumed.121.263200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jiang J, Li W, Wang X, Du Z, Chen J, Liu Y, Li W, Lu Z, Wang Y, Xu J. Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy. Front Cell Dev Biol 2022;10:902067. [DOI: 10.3389/fcell.2022.902067] [Reference Citation Analysis]